Induction Chemotherapy for Advanced Oral Cavity Cancer.

Abstract

PURPOSE OF REVIEW:

Head and neck cancer is a heterogeneous disease, comprising multiple subsites with diverse etiologic factors, pathology and molecular features, response to treatment, and prognosis. Systemic treatment is usually incorporated in the management of locally advanced head and neck squamous cell carcinoma, and the use of induction chemotherapy has theoretical benefits on reducing the risk of distant metastasis, provide an in vivo testing of response and tumor biology and the potential to allow a more personalized and less toxic local treatment after downstaging. The aim of this review is to access the role of induction chemotherapy in patients with locally advanced oral cavity cancer.

RECENT FINDINGS:

Clinical trials analyzing this treatment strategy in patients with resectable disease, followed by surgery, and in unresectable disease, followed by (chemo)radiotherapy or surgery are discussed, pointing out strengths and limitations of this data and highlighting the standard treatment in each clinical scenario. Future perspectives, including the incorporation of checkpoint inhibitors and biomarkers for patient selection are discussed. Surgery followed by (chemo)radiation is the standard of care for resectable oral cavity cancer patients, and chemoradiation is the standard for those considered as unresectable. Future trials with the incorporation of immunotherapy and better patient selection based on clinical and molecular biomarkers can bring new hopes for better therapeutic results in these patients.

• Authors: Thiago Bueno de Oliveira, Gustavo Nader Marta, Gilberto de Castro Junior, Luiz Paulo Kowalski
• Journal: Current oncology reports (Curr Oncol Rep) Vol. 23 Issue 11 Pg. 129 (08 27 2021) ISSN: 1534-6269 [Electronic] United States
• PMID: 34453267 (Publication Type: Journal Article, Review)
• Copyright: © 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Topics

• Combined Modality Therapy
• Humans
• Induction Chemotherapy
• Mouth Neoplasms (drug therapy, pathology, radiotherapy, surgery)
• Preoperative Care